Western blot quantification showed a notable decrease in procaspase 3 and 9 in the platinum(II)-treated cancer cells (Figure 12C,G) with observed cleaved caspase 3 in HT29-treated cells across all treatments with a significant increase, confirming the active cleavage of procaspase 3. Here, CASP3 is linked to cancer.